Skip Navigation

Natera CEO talks using DNA technology to change how disease is managed

Mad Money with Jim Cramer

Natera CEO talks using DNA technology to change how disease is managed

Jim Cramer chats with Natera CEO Steve Chapman about how the company is growing its reproductive health system and proprietary technology to alter how disease is managed worldwide.

07:35

Fri, Dec 6 20197:17 PM EST

Danny Moses on sports betting scandals in pro sports: 'The NBA has a big problem'

Danny Moses on sports betting scandals in pro sports: 'The NBA has a big problem'

3 hours ago

The Fed doesn't have an argument to cut rates this year, says Ares Head of Credit Kipp DeVeer

The Fed doesn't have an argument to cut rates this year, says Ares Head of Credit Kipp DeVeer

Nuveen's Dan Close on why the muni market is benefitting from the Fed's stance on rates

Nuveen's Dan Close on why the muni market is benefitting from the Fed's stance on rates

Investors need to respond to every short-term pop, says JPMorgan's Jason Hunter

Investors need to respond to every short-term pop, says JPMorgan's Jason Hunter

Ritholtz's Josh Brown: Outside of large caps, there's enough positive breadth in the market

Ritholtz's Josh Brown: Outside of large caps, there's enough positive breadth in the market

Danny Moses on sports betting scandals in pro sports: 'The NBA has a big problem'

Danny Moses on sports betting scandals in pro sports: 'The NBA has a big problem'

3 hours ago

The Fed doesn't have an argument to cut rates this year, says Ares Head of Credit Kipp DeVeer

The Fed doesn't have an argument to cut rates this year, says Ares Head of Credit Kipp DeVeer

Nuveen's Dan Close on why the muni market is benefitting from the Fed's stance on rates

Nuveen's Dan Close on why the muni market is benefitting from the Fed's stance on rates

Investors need to respond to every short-term pop, says JPMorgan's Jason Hunter

Investors need to respond to every short-term pop, says JPMorgan's Jason Hunter

Ritholtz's Josh Brown: Outside of large caps, there's enough positive breadth in the market

Ritholtz's Josh Brown: Outside of large caps, there's enough positive breadth in the market